AstraZeneca : Enhertu Approved In EU For Advanced Non-small Cell Lung Cancer Treatment

(RTTNews) - AstraZeneca Plc.(AZN.L, AZN) and Daiichi Sankyo's (DSKYF.PK) Enhertu has been approved in the European Union as monotherapy for the treatment of adult patients with advanced non-small cell lung cancer or NSCLC whose tumours have an activating HER2 (ERBB2) mutation and https://www.nasdaq.com/articles/astrazeneca-:-enhertu-approved-in-eu-for-advanced-non-small-cell-lung-cancer-treatment